EFSA's Scientific Committee has launched an open consultation on a Scientific Committee guidance on the assessment of aneugenicity. This document discusses the most appropriate in vivo follow-up for substances that are found to be aneugenic in vitro and how should the risk to human health be assessed for aneugenic substances.
Interested parties are invited to submit written comments by 31/05/2020. Please use the electronic template provided to submit comments and refer to the line and page numbers. To submit additional data to support your comments or files, there is an upload function available in the tool (for a maximum size of 1Mb file). Otherwise you can also contact specific unit’s functional mailbox: SCER.PublicConsult.EUS.006 [at] efsa.europa.eu. Please note that comments will not be considered if they:
- are submitted after the closing date of the consultation
- are presented in any form other than what is provided for in the instructions and template
- are not related to the contents of the document
- contain complaints against institutions, personal accusations, irrelevant or offensive statements or material
- are related to policy or risk management aspects, which are out of the scope of EFSA's activity.
EFSA will assess all comments which are submitted in line with the criteria above. The comments will be further considered by the EFSA Scientific Committee and taken into consideration if found to be relevant.
Persons or organisations participating in a Public Consultation of EFSA are responsible for ensuring that they hold all the rights necessary for their submissions and consequent publication by EFSA. Comments should inter alia be copyright cleared taking into account EFSA’s transparency policy and practice to publish all submissions. In case the submission reproduces third-party content in the form of charts, graphs or images, the required prior permissions of the right holder(s) should have been obtained by the PC respondent.
Publication of contribution
Contributions will be published and may be re-used by EFSA in a different context. It should be noted that contributions submitted by individuals in a personal capacity will be published as such, indicating the author’s first and family name, unless a substantial justification for protection is provided by the respondent. Contributions submitted on behalf of an organisation are also made publicly available and attributed to the organisation in question.
Submit comments (deadline: 31 May 2020)